Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MENDS: Melatonin in Children with Neuro-developmental Disorders and Impaired Sleep
2006-004025-28Phase 2Completed
- Sponsor
- Alder Hey Children's NHS Foundation Trust
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neurodevelopmental disorder (NDD) and sleep disorder comparing Melatonin with Placebo (2 arms). Primary endpoint: Total duration of night-time sleep. Started May 2007; status: completed.
02
Drugs
melatonin
03
Conditions
Neurodevelopmental disorder (NDD)sleep disorder
Beyond the preview
Go deeper on 2006-004025-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004025-28.